/

Empresas

Me

No verificado

MedLumics

Sobre qué escribimos

BiotecnologíaIndustriaMedicina - VariosSaludSanidad

2 Comunicados de prensa

Ver todos los comunicados de prensa

19/12/2024

Eventos

Ferias y Congresos

Industria

Salud

Sanidad

Medicina - Varios

Biotecnología

MedLumics is Proud to Announce the Completion of the FIM Study, With Successful Remapping at 3 Months, Demonstrating the Efficacy of the AblaView® Optically Guided Pulsed Field Ablation (PFA) System and Presentation at the AF Symposium 2025

Fuente

Editor

1.00

0

29/10/2024

Mercado laboral

Industria

Cardiología

Biotecnología

Sanidad

Salud

Material médico sanitario

Medicina - Varios

MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0